kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the EDIT dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for EDIT.

EDIT

Editas Medicine, Inc.
Biotechnology · Biotechnology
$144.45 sample
-0.74 (-0.51%) 1D
☆ Watch
Market cap
$229.6B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-12
Alerts
8
Price$144.45 +5.72% 3M daily closessample
152.49136.63
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 22INSInsider sell: 10% owner
  • Oct 19INSInsider buy: Director
  • Oct 12SEC8-K filed: material event
  • Oct 02INSInsider buy: Chief Executive Officer
  • Sep 29INSInsider buy: Chief Financial Officer
  • Sep 23INSInsider sell: EVP, Operations
  • Sep 17INSInsider sell: 10% owner
  • Sep 09INSInsider buy: Chief Executive Officer
Sign up to see the real EDIT record →

Company facts

SEC EDGAR registration
Name
Editas Medicine, Inc.
Sector
Biotechnology
Industry
Biotechnology
Smart-money score
+43sample, -100 to +100
Reporting currency
USD

Who is positioning in EDIT

sample
Insiders
18 insider transactions over 90 days, net selling, $189.2M
Congress
4 members traded over 90 days
Institutions · 13F
18 funds hold $3.2B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$7.8B +20.9% y/y
Q4 2024Q3 2026
Inventory$4.5B +11.3% y/y
Q4 2024Q3 2026
Accounts receivable$3.4B +10.7% y/y
Q4 2024Q3 2026
Total debt$9.4B +18.2% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$30.8B +1.7% 3M
Sample peer B
$122.2B +10.7% 3M
Sample peer C
$163.6B -5.8% 3M
Sample peer D
$177.1B +15.1% 3M
Sample peer E
$116.8B +7.8% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not EDIT's real figure. Nothing here is investment advice.